New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30 Novolog Mix 70/30 is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There…

The post New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 appeared first on DrugPatentWatch.

Comments are closed.